182 related articles for article (PubMed ID: 17545805)
21. Gastric cancer--new therapeutic options.
Macdonald JS
N Engl J Med; 2006 Jul; 355(1):76-7. PubMed ID: 16822999
[No Abstract] [Full Text] [Related]
22. Evolving role of chemoradiation in the adjuvant treatment of gastric cancer.
Leong T
Expert Rev Anticancer Ther; 2004 Aug; 4(4):585-94. PubMed ID: 15270662
[TBL] [Abstract][Full Text] [Related]
23. Cancer of the gastroesophageal junction: combined modality therapy.
Ilson DH
Surg Oncol Clin N Am; 2006 Oct; 15(4):803-24. PubMed ID: 17030275
[TBL] [Abstract][Full Text] [Related]
24. Chemotherapy for locally advanced and metastatic gastric cancer: state of the art and future perspectives.
Bittoni A; Maccaroni E; Scartozzi M; Berardi R; Cascinu S
Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):309-14. PubMed ID: 20496540
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.
Di Costanzo F; Gasperoni S; Manzione L; Bisagni G; Labianca R; Bravi S; Cortesi E; Carlini P; Bracci R; Tomao S; Messerini L; Arcangeli A; Torri V; Bilancia D; Floriani I; Tonato M; ; Dinota A; Strafiuso G; Corgna E; Porrozzi S; Boni C; Rondini E; Giunta A; Monzio Compagnoni B; Biagioni F; Cesari M; Fornarini G; Nelli F; Carboni M; Cognetti F; Enzo MR; Piga A; Romiti A; Olivetti A; Masoni L; De Stefanis M; Dalla Mola A; Camera S; Recchia F; De Filippis S; Scipioni L; Zironi S; Luppi G; Italia M; Banducci S; Pisani Leretti A; Massidda B; Ionta MT; Nicolosi A; Canaletti R; Biscottini B; Grigniani F; Di Costanzo F; Rovei R; Croce E; Carroccio R; Gilli G; Cavalli C; Olgiati A; Pandolfi U; Rossetti R; Natalini G; Foa P; Oldani S; Bruno L; Cascinu S; Catalano G; Catalano V; Lungarotti F; Farris A; Sarobba MG; Trignano M; Muscogiuri A; Francavilla F; Figoli F; Leoni M; Papiani G; Orselli G; Antimi M; Bellini V; Cabassi A; Contu A; Pazzola A; Frignano M; Lastraioli E; Saggese M; Bianchini D; Antonuzzo L; Mela M; Camisa R
J Natl Cancer Inst; 2008 Mar; 100(6):388-98. PubMed ID: 18334706
[TBL] [Abstract][Full Text] [Related]
26. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
Luu TD; Gaur P; Force SD; Staley CA; Mansour KA; Miller JI; Miller DL
Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
[TBL] [Abstract][Full Text] [Related]
27. [Resectable adenocarcinoma of the oesophagogastric junction care: which perioperative treatment?].
Créhange G; Bonnetain F; Chauffert B; Rat P; Bedenne L; Maingon P
Cancer Radiother; 2008 Sep; 12(5):365-73. PubMed ID: 18420440
[TBL] [Abstract][Full Text] [Related]
28. Advances in the treatment of patients with gastric adenocarcinoma.
Foukakis T; Lundell L; Gubanski M; Lind PA
Acta Oncol; 2007; 46(3):277-85. PubMed ID: 17450463
[TBL] [Abstract][Full Text] [Related]
29. Re: Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
Fazio N; Biffi R; Curigliano G; Lorizzo K; Zampino MG; de Braud F; Chiappa A; Roth A; Goldhirsch A
J Natl Cancer Inst; 2007 Sep; 99(17):1345-6; author reply 1346-7. PubMed ID: 17728219
[No Abstract] [Full Text] [Related]
30. Therapeutic options in gastric cancer: neoadjuvant chemotherapy vs postoperative chemoradiotherapy.
Jackson C; Mochlinski K; Cunningham D
Oncology (Williston Park); 2007 Aug; 21(9):1084-7; discussion 1090, 1096-8, 1101. PubMed ID: 17910312
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant therapy in gastric and cardia cancer: should we irradiate?
Van Laethem JL; Demols A
Curr Opin Oncol; 2006 Jul; 18(4):381-5. PubMed ID: 16721135
[TBL] [Abstract][Full Text] [Related]
32. Multimodality therapy for the curative treatment of cancer of the esophagus and gastroesophageal junction.
Ku GY; Ilson DH
Expert Rev Anticancer Ther; 2008 Dec; 8(12):1953-64. PubMed ID: 19046115
[TBL] [Abstract][Full Text] [Related]
33. The postoperative component of MAGIC chemotherapy is associated with improved prognosis following surgical resection in gastric and gastrooesophageal junction adenocarcinomas.
Mirza A; Pritchard S; Welch I
Int J Surg Oncol; 2013; 2013():781742. PubMed ID: 24163764
[TBL] [Abstract][Full Text] [Related]
34. The role of chemotherapy in the treatment of esophageal cancer.
Kelsen DP
Chest Surg Clin N Am; 1994 Feb; 4(1):173-84. PubMed ID: 8055280
[TBL] [Abstract][Full Text] [Related]
35. Induction chemotherapy in Barrett cancer: influence on surgical risk and outcome.
Siewert JR; Lordick F; Ott K; Stein HJ; Weber WA; Becker K; Peschel C; Fink U; Schwaiger M
Ann Surg; 2007 Oct; 246(4):624-8; discussion 628-31. PubMed ID: 17893499
[TBL] [Abstract][Full Text] [Related]
36. A preliminary study on the postoperative survival of patients given aspirin after resection for squamous cell carcinoma of the esophagus or adenocarcinoma of the cardia.
Liu JF; Jamieson GG; Wu TC; Zhu GJ; Drew PA
Ann Surg Oncol; 2009 May; 16(5):1397-402. PubMed ID: 19241108
[TBL] [Abstract][Full Text] [Related]
37. Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer.
Jung JY; Kwon JH; Kim JH; Song HH; Kim I; Lee KS; Kim HJ; Zang DY; Ahn JS; Lee JA; Park YI
Oncol Rep; 2009 Feb; 21(2):523-9. PubMed ID: 19148531
[TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant chemotherapy and surgery for esophageal adenocarcinoma: prognostic value of circumferential resection margin and stratification of N1 category.
Saha AK; Sutton C; Rotimi O; Dexter S; Sue-Ling H; Sarela AI
Ann Surg Oncol; 2009 May; 16(5):1364-70. PubMed ID: 19252949
[TBL] [Abstract][Full Text] [Related]
39. Weekly infusional high-dose fluorouracil (HD-FU), HD-FU plus folinic acid (HD-FU/FA), or HD-FU/FA plus biweekly cisplatin in advanced gastric cancer: randomized phase II trial 40953 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group and the Arbeitsgemeinschaft Internistische Onkologie.
Lutz MP; Wilke H; Wagener DJ; Vanhoefer U; Jeziorski K; Hegewisch-Becker S; Balleisen L; Joossens E; Jansen RL; Debois M; Bethe U; Praet M; Wils J; Van Cutsem E; ;
J Clin Oncol; 2007 Jun; 25(18):2580-5. PubMed ID: 17577037
[TBL] [Abstract][Full Text] [Related]
40. Survivin expression in gastric cancer: Association with histomorphological response to neoadjuvant therapy and prognosis.
Vallböhmer D; Drebber U; Schneider PM; Baldus S; Bollschweiler E; Brabender J; Warnecke-Eberz U; Mönig S; Hölscher AH; Metzger R
J Surg Oncol; 2009 Jun; 99(7):409-13. PubMed ID: 19347901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
